The United States accounts for a significant share of the global remote patient monitoring (RPM) market. The U.S. RPM market ...

SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its ...

"Despite clear congressional mandates and FDA authorization, the Drug Enforcement Administration failed to act within the timelines required by law, resulting in years-long delay of medical cannabis ...

This Christmas season, President Trump's executive action to advance rescheduling and medical research has finally exposed the truth: the DEA marijuana obstruction was never about public safety. It ...

LAVAL, QC / ACCESS Newswire / December 23, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company") and its subsidiary 1261229 B.C. Ltd. (the "Issuer" and, together with the Company, ...

ASPS trend reporting highlights facelift combined with eyelid surgery as a leading 2025 combination; national procedure ...

From combination surgeries to advanced skin therapies, The Naderi Center outlines how patients nationwide are prioritizing ...

Expedited Development Enabled by RMAT and Breakthrough Therapy StatusClinical Trial Initiation in 2026, FDA Approval Target ...

Weekly Oral Helicase-Primase Inhibitor Programs' Early Data Potentially Supportive of First New Treatment for Recurrent ...

Digital patient monitoring systems (DPMS) market refer to a broad spectrum of technologies designed to continuously monitor ...

Agreement with the U.S. government addresses prescription drug costs and encourages other wealthy nations to reward ...

Predicting how a person’s heart will respond to a new medicine remains one of the most persistent blind spots in drug ...